-
Board Certification
American Board of Internal Medicine (Internal Medicine)American Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Patient Rating
5.0 /5( out of 61 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy.December 28, 2023HUNTSMAN CANCER CENTERDr. Tashi was very knowledgeable and helped me to understand my diagnosis better.
December 28, 2023HUNTSMAN CANCER CENTERWhat a truly outstanding doctor Dr. Tashi is. He spent 70 minutes with us and answered all our concerns and questions. Helped with the pros and cons of my health issue.
December 07, 2023HUNTSMAN CANCER CENTERIn my near 70 years of experience I¿ve met few physicians of his caliber. You are lucky to have him and your patients, including me, are even luckier.
November 30, 2023HUNTSMAN CANCER CENTERDr. Tashi was well informed about my conditions, did an excellent job listening, answering questions, and he has a pleasant demeanor.
November 16, 2023HUNTSMAN CANCER CENTERVery caring and knowledgeable about PV
November 09, 2023SOUTH JORDAN HEALTH CENTERRepeat my first comments. Dr Tashi is awesome!
October 06, 2023HUNTSMAN CANCER CENTERHe explained everything in a way that was easy to understand. I didn't feel rushed and felt comfortable asking my questions.
October 05, 2023HUNTSMAN CANCER CENTERDr. Tashi is a kind and caring man. He doesn't rush, he listen and explains things in away that I can understand. I have many problems and DR. Tashi is willing to work with my other doctors to help figure out how to best help me. Deborah
August 04, 2023HUNTSMAN CANCER CENTERSuperb
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Primary Academic Divisions Hematology
Board Certification American Board of Internal Medicine (Internal Medicine)American Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Education history
Graduate Training Master of Science in Clinical Investigation - University of Utah M.S.C.I Hematology/Oncology - University of Utah Fellow Residency Internal Medicine - Creighton University Resident Internal Medicine - Pingtung Christian Hospital Resident Internship Internal Medicine - MacKay Memorial Hospital Intern Medicine - Chang Gung University School of Medicine M.D. Selected Publications
Journal Article
- Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Rafferty M, Butt NM, Oh ST, Wortmann F, Ungerstedt J, Guilarte M, Taparia M, Kuykendall AT, Arana Yi C, Ogbogu P, Gaudy-Marqueste C, Mattsson M, Shomali W, Giannetti MP, Bidollari I, Lin HM, Sulllivan E, Mar B, Scherber R, Roche M, Akin C, Maurer M (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid, 2(6), EVIDoa2200339. (Read full article)
- Tashi T, Yu J, Pandya S, Dieyi C, Scherber R, Parasuraman S (2023). Trends in overall mortality among US veterans with primary myelofibrosis. BMC Cancer, 23(1), 48. (Read full article)
- Chuah YY, Tashi T, Kuo CJ (2022). An unexpected cause of Cullen's sign: rupture of hepatocellular carcinoma. Br J Hosp Med (Lond), 83(11), 1. (Read full article)
- Verstovsek S, Mesa R, Mascarenhas J, Tashi T, Shih W, Sato T, Urbanski R, Zagrijtschuk O, Zimmerman C (2022). MPN-546 A Single-Arm Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in North American Adults With Essential Thrombocythemia. Clin Lymphoma Myeloma Leuk, 22 Suppl 2, S342-S343. (Read full article)
- Feusier JE, Arunachalam S, Tashi T, Baker MJ, VanSant-Webb C, Ferdig A, Welm BE, Rodriguez-Flores JL, Ours C, Jorde LB, Prchal JT, Mason CC (2021). Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. Blood Cancer Discov, 2(3), 226-237. (Read full article)
- Gangaraju R, Song J, Kim SJ, Tashi T, Reeves BN, Sundar KM, Thiagarajan P, Prchal JT (2019). Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia. Blood Adv, 4(6), 1115-1130. (Read full article)
Review
- Tashi T, Deininger MW (2023). Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms. [Review]. Immunol Allergy Clin North Am, 43(4), 723-741. (Read full article)
- Tashi T (2022). Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera. [Review]. Fed Pract, 39(Suppl 2), S43-S46. (Read full article)
Case Report
- Chuah YY, Tashi T, Lee YY, Fu TY, Shih CA (2020). Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis : a rare and dismal condition. Acta Gastroenterol Belg, 83(1), 77-80. (Read full article)
Editorial
- Song J, Tashi T, Prchal JT (2019). Editorial Comment on: Inhibition of Suicidal Erythrocyte Death by Chronic Hypoxia by Tang et al. (From: Tang F, Feng L, Li R, Wang W, Liu H, Yang Q, Ge R-L. High Alt Med Biol 2019;20:112-119; DOI: 10.1089/ham.2017.0159). High Alt Med Biol, 20(2), 120-121. (Read full article)
-
News & Podcasts
Huntsman Cancer Institute News